Ledger.Open graph →
SEC Form D · filed January 22, 2021

Verve Therapeutics, Inc

Offering
$94.0M
Sold
$94.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Burt Adelman · Cambridge, MADirectorJohn Evans · Grand Rapids, MIDirectorKrishna Yeshwant · New York, NYDirectorAndrew Bellinger · Cambridge, MAExecAndrew Bellinger · Cambridge, MAExecSekar Kathiresan · Cambridge, MAExec · DirectorAndrew Ashe · Cambridge, MAExecAnthony Philippakis · Cambridge, MADirectorSekar Kathiresan · Cambridge, MAExec · DirectorJohn Evans · Charlotte, VTDirectorBurt Adelman · Cambridge, MADirectorAndrew Ashe · Cambridge, MAExecAnthony Philippakis · Cambridge, MADirectorKrishna Yeshwant · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗